Evidence map›Paper›PMID 36992390›Full record

ReviewViruses2023

Hop Latent Viroid: A Hidden Threat to the Cannabis Industry.

Charith Raj Adkar-Purushothama, Teruo Sano, Jean-Pierre Perreault

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Optimizing Growth Regulator Concentrations forPlants (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Viroid ecology in hops (Frontiers in microbiology · 2025
    Article
  5. Article
  6. Integrated Management of Pathogens and Microbes inPlants (Basel, Switzerland) · 2024
    Review
  7. Article
  8. Article
  9. Challenges toInternational journal of molecular sciences · 2023
    Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Charith Raj Adkar-PurushothamaRNA Group, Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, PQ J1E 4K8, Canada.ORCID 0000-0001-8868-6008
Teruo SanoFaculty of Agriculture and Life Science, Hirosaki University, Hirosaki 036-8561, Japan.
Jean-Pierre PerreaultRNA Group, Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, PQ J1E 4K8, Canada.
Université de Sherbrooke · CAHirosaki University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hop latent viroid (HLVd) is the biggest concern for cannabis and hop growers worldwide. Although most HLVd-infected plants remain asymptomatic, research on hops has demonstrated a decrease in both the α-bitter acid and terpene content of hop cones, which affects their economic value. The HLVd-associated "dudding" or "duds" disease of cannabis was first reported in 2019 in California. Since then, the disease has become widespread in cannabis-growing facilities across North America. Although severe yield loss associated with duds disease has been recorded, little scientific information is available to growers in order to contain HLVd. Consequently, this review aims to summarise all of the scientific information available on HLVd so as to be able to understand the effect of HLVd on yield loss, cannabinoid content, terpene profile, disease management and inform crop protection strategies.

Indexed as

CannabisCarlavirusPlant DiseasesViroidsHost SpecificityHumulusNorth Americacannabis diseasecannabis pathogenduddingdudsHLVdhop latent viroidhop viroidviroidviroid disease

Identifiers

PMID36992390
PMCPMC10053334
OpenAlexW4323313985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.